SENSEX NIFTY

Ranbaxy Laboratories

Jan 30, 2015 at 16:52 | Source: Moneycontrol.com
Brokerage house Motilal Oswal is bullish on Ranbaxy Laboratories and has recommended buy rating on the stock with a target price of Rs 800, in its research report dated January 28, 2015.
Jan 30, 2015 at 16:50 | Source: Moneycontrol.com
KRChoksey is bullish on Ranbaxy Laboratories and has recommended accumulate rating on the stock with a target price of Rs 780 in its January 29, 2015 research report.
Jan 28, 2015 at 15:08 | Source: CNBC-TV18
Speaking to CNBC-TV18, Sarabjit Kaur Nangra of Angel Broking said on the bottomline, margins suffered due to forex loss. The drug maker reported a forex loss of Rs 132.6 crore versus gain of Rs 10.1 crore from a year ago period.
Jan 28, 2015 at 15:03 | Source: CNBC-TV18
CNBC-TV18's Sonia Shenoy lists out stocks that you should focus on Asian Paints, Maruti, HDFC Bank, Lupin, Tata Motors, Tata Motors DVR, Titan, Ranbaxy
Jan 28, 2015 at 14:49 | Source: Moneycontrol.com
Troubled pharmaceuticals firm Ranbaxy Laboratories consolidated posted a consolidated net loss of Rs 1,030 crore compared to Rs 159 crore in the same quarter last year. Revenues dipped to Rs 2618.8 crore, compared to Rs 2,893.9 crore YoY.
Jan 28, 2015 at 11:15 | Source: CNBC-TV18
Ranbaxy Laboratories, which will soon become a part of Sun Pharma, will announce its third quarter (October-December) earnings today. Analysts expect the quarter to be a good one due to Diovan generic (is used to treat high blood pressure).
Jan 28, 2015 at 08:23 | Source: CNBC-TV18
Bharti Airtel | Tata Motors | Idea Cellular | Yes Bank | GMR Infrastructure | Amara Raja Batteries | Titan Company | Sadbhav Engineering | Gammon Infrastructure | Larsen and Toubro | Ranbaxy Labs | Hindalco Industries | GE Shipping | Cholamandalam Investment | GHCL | Karnataka Bank and Gati are stocks, which are in the news today.
Jan 27, 2015 at 22:22 | Source: CNBC-TV18
Ranbaxy has lost out on its last big drug opportunity in the US market. The US drug regulator has denied the company 180-day exclusivity for the generic version of heart burn drug Nexium. However Archana Shukla reports that Ranbaxy's loss means good times for global rival Teva and Cipla.
Jan 27, 2015 at 14:59 | Source: CNBC-TV18
CNBC-TV18's Sonia Shenoy lists out stocks that you should focus on Maruti, Ranbaxy, BEL, Max India, HDIL, Tata Motors, Asian paints, Cipla, HDFC bank
Jan 27, 2015 at 14:19 | Source: CNBC-TV18
The US FDAs decision to revoke the 180-day exclusivity cover extended to Indian firm Ranbaxy to sell a generic version of the worlds second-largest selling drug esomeprazole is likely to help rival Cipla, according to Vivek Kumar, research analyst, SBICap Securities.
Messages on Ranbaxy Laboratories »

Market Statistician

Platinum Member

11827 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 15:14 hrs, the share was quoting at Rs 545.65, up Rs 2.50, or 0.46%. See more

3.15 PM Jul 8th 2014

Market Statistician

Platinum Member

11827 Followers

Ranbaxy Labs  

At 15:14 hrs, Ranbaxy Laboratories was trading at Rs 545.65 up 0.46%, with a huge increase in its volume of shares traded. Till now over 220,541 shares were traded as compared to its 5-day average of 106,981 shares.

3.15 PM Jul 8th 2014

Market Statistician

Platinum Member

11827 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 14:14 hrs, the share was quoting at Rs 550.20, up Rs 7.05, or 1.30%. See more

2.15 PM Jul 8th 2014

Market Statistician

Platinum Member

11827 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 13:14 hrs, the share was quoting at Rs 552.10, up Rs 8.95, or 1.65%. See more

1.15 PM Jul 8th 2014

Market Statistician

Platinum Member

11827 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 12:14 hrs, the share was quoting at Rs 550.65, up Rs 7.50, or 1.38%. See more

12.15 PM Jul 8th 2014

Market Statistician

Platinum Member

11827 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 11:14 hrs, the share was quoting at Rs 552.35, up Rs 9.20, or 1.69%. See more

11.15 AM Jul 8th 2014

Market Statistician

Platinum Member

11827 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 15:14 hrs, the share was quoting at Rs 533.20, down Rs 0.10, or 0.02%. See more

3.15 PM Jul 4th 2014

Market Statistician

Platinum Member

11827 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 14:14 hrs, the share was quoting at Rs 532.20, down Rs 1.10, or 0.21%. See more

2.15 PM Jul 4th 2014

Market Statistician

Platinum Member

11827 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 13:13 hrs, the share was quoting at Rs 531.20, down Rs 2.10, or 0.39%. See more

1.15 PM Jul 4th 2014

Market Statistician

Platinum Member

11827 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 12:14 hrs, the share was quoting at Rs 532.15, down Rs 1.15, or 0.22%. See more

12.15 PM Jul 4th 2014

News across the web »
Jan 25, 2015 at 00:15 | Source: FirstPost
Jan 23, 2015 at 11:54 | Source: FirstPost